rs10458926
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_003737.4(DCHS1):c.7147-9A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.17 in 1,612,860 control chromosomes in the GnomAD database, including 24,624 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.16 ( 2262 hom., cov: 33)
Exomes 𝑓: 0.17 ( 22362 hom. )
Consequence
DCHS1
NM_003737.4 intron
NM_003737.4 intron
Scores
2
Splicing: ADA: 0.00003436
2
Clinical Significance
Conservation
PhyloP100: -0.403
Publications
11 publications found
Genes affected
DCHS1 (HGNC:13681): (dachsous cadherin-related 1) This gene is a member of the cadherin superfamily whose members encode calcium-dependent cell-cell adhesion molecules. The encoded protein has a signal peptide, 27 cadherin repeat domains and a unique cytoplasmic region. This particular cadherin family member is expressed in fibroblasts but not in melanocytes or keratinocytes. The cell-cell adhesion of fibroblasts is thought to be necessary for wound healing. [provided by RefSeq, Jul 2008]
DCHS1 Gene-Disease associations (from GenCC):
- mitral valve prolapse, myxomatous 2Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- van Maldergem syndrome 1Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia
- familial mitral valve prolapseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- van Maldergem syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 11-6624877-T-C is Benign according to our data. Variant chr11-6624877-T-C is described in ClinVar as Benign. ClinVar VariationId is 259142.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.336 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| DCHS1 | NM_003737.4 | c.7147-9A>G | intron_variant | Intron 19 of 20 | ENST00000299441.5 | NP_003728.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| DCHS1 | ENST00000299441.5 | c.7147-9A>G | intron_variant | Intron 19 of 20 | 1 | NM_003737.4 | ENSP00000299441.3 |
Frequencies
GnomAD3 genomes AF: 0.165 AC: 25064AN: 151972Hom.: 2263 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
25064
AN:
151972
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.185 AC: 46104AN: 249544 AF XY: 0.186 show subpopulations
GnomAD2 exomes
AF:
AC:
46104
AN:
249544
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.171 AC: 249790AN: 1460768Hom.: 22362 Cov.: 34 AF XY: 0.172 AC XY: 124826AN XY: 726592 show subpopulations
GnomAD4 exome
AF:
AC:
249790
AN:
1460768
Hom.:
Cov.:
34
AF XY:
AC XY:
124826
AN XY:
726592
show subpopulations
African (AFR)
AF:
AC:
3866
AN:
33476
American (AMR)
AF:
AC:
7830
AN:
44604
Ashkenazi Jewish (ASJ)
AF:
AC:
6155
AN:
26120
East Asian (EAS)
AF:
AC:
13512
AN:
39664
South Asian (SAS)
AF:
AC:
15693
AN:
86148
European-Finnish (FIN)
AF:
AC:
7601
AN:
53312
Middle Eastern (MID)
AF:
AC:
1388
AN:
5762
European-Non Finnish (NFE)
AF:
AC:
182539
AN:
1111350
Other (OTH)
AF:
AC:
11206
AN:
60332
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
11023
22047
33070
44094
55117
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
6506
13012
19518
26024
32530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.165 AC: 25073AN: 152092Hom.: 2262 Cov.: 33 AF XY: 0.165 AC XY: 12272AN XY: 74328 show subpopulations
GnomAD4 genome
AF:
AC:
25073
AN:
152092
Hom.:
Cov.:
33
AF XY:
AC XY:
12272
AN XY:
74328
show subpopulations
African (AFR)
AF:
AC:
4856
AN:
41498
American (AMR)
AF:
AC:
3048
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
848
AN:
3470
East Asian (EAS)
AF:
AC:
1798
AN:
5138
South Asian (SAS)
AF:
AC:
928
AN:
4818
European-Finnish (FIN)
AF:
AC:
1444
AN:
10592
Middle Eastern (MID)
AF:
AC:
83
AN:
294
European-Non Finnish (NFE)
AF:
AC:
11544
AN:
67980
Other (OTH)
AF:
AC:
378
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1071
2141
3212
4282
5353
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
276
552
828
1104
1380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
833
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jul 06, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.